Cardiac Pharmacology Section 14- PCSK9 Inhibitors

TOPICS: Pcsk9, ldl receptor, alirocumab, evolucumab, ldl, hdl, triglycerides, subcutaneous, skin rash, myalgia, nasopharyngitis